$SPCB
SuperCom Ltd Stock $spcb

$spcb Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000117891324001418 Filed on April 22, 2024

Income Statement

Concept	2023 Q4	2023
Revenue	$5.668M	$26.57M
YoY Change	10.7%	50.55%
Cost Of Revenue	$3.320M	$16.35M
YoY Change	-4.6%	45.16%
Gross Profit	$2.348M	$10.22M
YoY Change	43.17%	60.03%
Gross Profit Margin	41.43%	38.48%
Selling, General & Admin	$2.534M	$7.660M
YoY Change	35.51%	-2.33%
% of Gross Profit	107.92%	74.93%
Research & Development	$674.0K	$3.110M
YoY Change	2.12%	-8.85%
% of Gross Profit	28.71%	30.42%
Depreciation & Amortization	$1.670M	$2.980M
YoY Change		10.74%
% of Gross Profit	71.12%	29.15%
Operating Expenses	$4.822M	$13.58M
YoY Change	31.39%	9.59%
Operating Profit	-$2.474M	-$3.359M
YoY Change	21.87%	-44.06%
Interest Expense	$896.0K	-$663.0K
YoY Change	-41.44%	-62.11%
% of Operating Profit
Other Income/Expense, Net		-$663.0K
YoY Change		-62.14%
Pretax Income	-$1.578M	-$4.022M
YoY Change	215.6%	-48.14%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.578M	-$4.022M
YoY Change	689.0%	-46.06%
Net Earnings / Revenue	-27.84%	-15.14%
Basic Earnings Per Share		-$0.60
Diluted Earnings Per Share	-$0.23	-$0.59
COMMON SHARES
Basic Shares Outstanding	13.29M shares	6.762M shares
Diluted Shares Outstanding		6.762M shares

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.206M	$5.206M
YoY Change	28.86%	28.86%
Cash & Equivalents	$5.206M	$5.206M
Short-Term Investments
Other Short-Term Assets	$7.396M	$7.396M
YoY Change	23.89%	23.89%
Inventory	$2.503M	$2.503M
Prepaid Expenses	$133.0K
Receivables	$13.36M	$13.36M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$28.46M	$28.46M
YoY Change	8.26%	8.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.701M	$3.188M
YoY Change	64.7%	94.39%
Goodwill	$7.026M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$988.0K	$501.0K
YoY Change	0.82%	-48.88%
Total Long-Term Assets	$16.29M	$16.29M
YoY Change	3.43%	3.43%
TOTAL ASSETS
Total Short-Term Assets	$28.46M	$28.46M
Total Long-Term Assets	$16.29M	$16.29M
Total Assets	$44.75M	$44.75M
YoY Change	6.45%	6.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.883M	$1.883M
YoY Change	48.27%	48.27%
Accrued Expenses	$1.901M	$1.901M
YoY Change	-13.2%	-13.2%
Deferred Revenue
YoY Change
Short-Term Debt	$792.0K	$792.0K
YoY Change	-12.0%	-12.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.402M	$5.402M
YoY Change	3.11%	3.09%
LONG-TERM LIABILITIES
Long-Term Debt	$33.95M	$33.95M
YoY Change	4.15%	4.15%
Other Long-Term Liabilities	$413.0K	$413.0K
YoY Change	-54.11%	-54.11%
Total Long-Term Liabilities	$34.37M	$34.37M
YoY Change	2.06%	2.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.402M	$5.402M
Total Long-Term Liabilities	$34.37M	$34.37M
Total Liabilities	$39.94M	$39.94M
YoY Change	2.64%	2.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$106.9M
YoY Change	3.91%
Common Stock	$111.8M
YoY Change	5.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.816M	$4.816M
YoY Change
Total Liabilities & Shareholders Equity	$44.75M	$44.75M
YoY Change	6.45%	6.45%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.578M	-$4.022M
YoY Change	689.0%	-46.06%
Depreciation, Depletion And Amortization	$1.670M	$2.980M
YoY Change		10.74%
Cash From Operating Activities	$1.043M	-$2.367M
YoY Change		-49.14%
INVESTING ACTIVITIES
Capital Expenditures	$1.636M	$3.366M
YoY Change		542.37%
Acquisitions
YoY Change
Other Investing Activities	$30.00K	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$1.616M	-$3.366M
YoY Change		53.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$4.673M	$6.873M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.625M	6.805M
YoY Change		0.9%
NET CHANGE
Cash From Operating Activities	1.043M	-2.367M
Cash From Investing Activities	-1.616M	-3.366M
Cash From Financing Activities	4.625M	6.805M
Net Change In Cash	4.052M	1.072M
YoY Change		-1182.83%
FREE CASH FLOW
Cash From Operating Activities	$1.043M	-$2.367M
Capital Expenditures	$1.636M	$3.366M
Free Cash Flow	-$593.0K	-$5.733M
YoY Change		10.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y7M20D
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Tel Aviv
CY2023	dei	Security12b Title Security12bTitle	Ordinary Shares, NIS 2.5 Par Value
CY2023	dei	Trading Symbol TradingSymbol	SPCB
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5206000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4042000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	371000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	463000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	14124000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	12667000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13357000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10852000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1742000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2239000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2503000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3411000	usd
CY2023Q4	spcb	Finite Lived Patents Gross Current FiniteLivedPatentsGrossCurrent	5283000	usd
CY2022Q4	spcb	Finite Lived Patents Gross Current FiniteLivedPatentsGrossCurrent	5283000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	28462000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	26290000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2701000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1640000	usd
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5576000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	5617000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	7026000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	792000	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	900000	usd
CY2023Q4	spcb	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	485000	usd
CY2022Q4	spcb	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	469000	usd
CY2023Q4	spcb	Short Term Operating Lease Liabilities ShortTermOperatingLeaseLiabilities	401000	usd
CY2022Q4	spcb	Short Term Operating Lease Liabilities ShortTermOperatingLeaseLiabilities	381000	usd
CY2023Q4	spcb	Deferred Revenue And Advances From Customers Current DeferredRevenueAndAdvancesFromCustomersCurrent	726000	usd
CY2022Q4	spcb	Deferred Revenue And Advances From Customers Current DeferredRevenueAndAdvancesFromCustomersCurrent	715000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5402000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5239000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	33952000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	32600000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	34535000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	33670000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	39937000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	38909000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.5
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	2.5
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13291028	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13291028	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4206327	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4206327	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	9094000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3057000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	102670000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	103000000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-106948000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4816000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44753000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42040000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	26570000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	17649000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16347000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	11261000	usd
CY2023	us-gaap	Gross Profit GrossProfit	10223000	usd
CY2022	us-gaap	Gross Profit GrossProfit	6388000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3110000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3412000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2200000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5460000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5186000	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-2812000	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1138000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	13582000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	12393000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3359000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7756000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-299000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4022000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-7457000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	4392000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	138000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-7457000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3131000	usd
CY2023	spcb	Stock Issued During Period Value Conversion Of Loans StockIssuedDuringPeriodValueConversionOfLoans	892000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	243000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4022000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4022000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-7457000	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-670000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	640000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-728000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-12000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	616000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-128000	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-325000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-780000	usd
CY2023	spcb	Increase Decrease In Accrued Severance Pay IncreaseDecreaseInAccruedSeverancePay	-41000	usd
CY2022	spcb	Increase Decrease In Accrued Severance Pay IncreaseDecreaseInAccruedSeverancePay	51000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-604000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-436000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	51000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-513000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2367000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4654000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1714000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	524000	usd
CY2022	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1613000	usd
CY2023	spcb	Decrease Increase In Severance Pay Fund Classified Investing Activities DecreaseIncreaseInSeverancePayFundClassifiedInvestingActivities	0	usd
CY2022	spcb	Decrease Increase In Severance Pay Fund Classified Investing Activities DecreaseIncreaseInSeverancePayFundClassifiedInvestingActivities	52000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3366000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2189000	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-68000	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-4000	usd
CY2023	spcb	Proceeds From Increase In Short Term Credit ProceedsFromIncreaseInShortTermCredit	0	usd
CY2022	spcb	Proceeds From Increase In Short Term Credit ProceedsFromIncreaseInShortTermCredit	900000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6805000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6744000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1072000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-99000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4505000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4604000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4505000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	spcb	Conversion Of Loans And Other Liabilities Into Ordinary Shares ConversionOfLoansAndOtherLiabilitiesIntoOrdinaryShares	2251000	usd
CY2022	spcb	Conversion Of Loans And Other Liabilities Into Ordinary Shares ConversionOfLoansAndOtherLiabilitiesIntoOrdinaryShares	212000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-106948000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2367000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4654000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5577000	usd
CY2023Q4	spcb	Net Working Capital NetWorkingCapital	23059000	usd
CY2018Q4	spcb	Secured Financing SecuredFinancing	20000000	usd
CY2020Q4	spcb	Remaining Available Secured Financing RemainingAvailableSecuredFinancing	6000000	usd
CY2021Q1	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt	12000000	usd
CY2021Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5848000	usd
CY2021	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt	12000000	usd
CY2021	us-gaap	Debt Instrument Term DebtInstrumentTerm	P2Y
CY2023	us-gaap	Proceeds From Issuance Of Subordinated Long Term Debt ProceedsFromIssuanceOfSubordinatedLongTermDebt	500000	usd
CY2023Q4	us-gaap	Subordinated Debt SubordinatedDebt	16290000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	110000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	547000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	38000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	509000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	26570000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	26570000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	17649000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	17649000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:7%;vertical-align:top"> <div style="line-height:1.25"> </div> </td> <td style="width:3%;vertical-align:top"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">q.</span></span></div> </td> <td style="width:90%;vertical-align:top"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concentrations of credit risk:</span></span></div> <div style="line-height:1.25"> </div> <div style="line-height:1.25;font-family:'Times New Roman',Times,serif"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash deposits and trade receivables. The Company’s trade receivables are derived from sales to customers located primarily in Europe, Africa, the United States and South America. The Company performs ongoing credit evaluations of its customers’ financial condition. The allowance for doubtful accounts is determined with respect to specific debts that the Company has determined to be doubtful of collection.</span></span></div> <div style="line-height:1.25"> </div> <div style="line-height:1.25"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Cash and cash equivalents and restricted cash deposits are deposited with major banks in Israel and the United States. Management believes that such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial instruments. The Company has no significant off-balance-sheet concentration of credit risk.</span></span></div> </div> </div> </td> </tr> </table>
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	192000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	181000	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1713000	shares
CY2023Q4	spcb	Right Of Use Leased Assets And Corresponding Liabilities RightOfUseLeasedAssetsAndCorrespondingLiabilities	1200000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	224000	usd
CY2023Q4	spcb	Advance To Suppliers Current AdvanceToSuppliersCurrent	337000	usd
CY2022Q4	spcb	Advance To Suppliers Current AdvanceToSuppliersCurrent	337000	usd
CY2023Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	479000	usd
CY2022Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	740000	usd
CY2023Q4	us-gaap	Guaranty Assets GuarantyAssets	662000	usd
CY2022Q4	us-gaap	Guaranty Assets GuarantyAssets	621000	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	131000	usd
CY2022Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	317000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1742000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2239000	usd
CY2023Q4	spcb	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	485000	usd
CY2022Q4	spcb	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	469000	usd
CY2023Q4	us-gaap	Guarantee Obligations Current Carrying Value GuaranteeObligationsCurrentCarryingValue	350000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7756000	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1380000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	1726000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1123000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1685000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2503000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3411000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2395000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2215000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8914000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7200000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6213000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5560000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2701000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1640000	usd
CY2023	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	1714000	usd
CY2022	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	524000	usd
CY2023	us-gaap	Depreciation Depreciation	653000	usd
CY2022	us-gaap	Depreciation Depreciation	688000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1693000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1607000	usd
CY2023Q4	spcb	Accrued Management Services AccruedManagementServices	86000	usd
CY2022Q4	spcb	Accrued Management Services AccruedManagementServices	86000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	207000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	202000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	437000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	25837000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	28622000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	25414000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	423000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	423000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1880000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-7013000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2142000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-743000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4022000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7756000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4022000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-594000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-181000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-299000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.00001
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	800937	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0384	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0284	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.91	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y6M10D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	811050	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.58
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	21388	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.3
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	22000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.23
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	800937	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.25
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	250	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1650	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	10625	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.17
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	9625	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.79
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	822175	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	5438	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	10.7
CY2022	spcb	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsGrantsInPeriodGross	800937	shares
CY2022	spcb	Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.25
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	199297	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	3.94
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	9625	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	3.79
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	597453	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.51
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	539000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward	2.66
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	243000	usd
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	822175	shares
CY2023Q4	spcb	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Aggregate Intrinsic Value ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsAggregateIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	416975	shares
CY2023Q4	spcb	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Aggregate Intrinsic Value ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsAggregateIntrinsicValue	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	7000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-6005000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-663000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1751000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4022000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7756000	usd
CY2023	us-gaap	Revenues Revenues	26570000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3359000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	7026000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2701000	usd
CY2022	us-gaap	Revenues Revenues	17649000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-6005000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	7026000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1640000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3359000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1000000	usd
CY2023	spcb	Other Income Or Expense OtherIncomeOrExpense	1355000	usd
CY2022	spcb	Other Income Or Expense OtherIncomeOrExpense	138000	usd
CY2023	spcb	Other Expense Net OtherExpenseNet	-2812000	usd
CY2022	spcb	Other Expense Net OtherExpenseNet	-1138000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11667000	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	1457000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	1000000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	14124000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	12667000	usd
CY2023	us-gaap	Interest And Debt Expense InterestAndDebtExpense	2512000	usd
CY2022	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1770000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-464000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	19000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-663000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1751000	usd
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001291855
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-33668
CY2023	dei	Entity Registrant Name EntityRegistrantName	SUPERCOM LTD.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L3
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	3 Rothschild Street
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	6688106
CY2023	dei	Entity Address Country EntityAddressCountry	IL
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13291028	shares
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Auditor Name AuditorName	Yarel + Partners
CY2023	dei	Auditor Firm AuditorFirmId	1024
CY2023	dei	Auditor Location AuditorLocation	Tel-Aviv, Israel
CY2022Q4	us-gaap	Goodwill Goodwill	7026000	usd
CY2023Q4	spcb	Other Long Term Assets OtherLongTermAssets	988000	usd
CY2022Q4	spcb	Other Long Term Assets OtherLongTermAssets	1467000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	16291000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	15750000	usd
CY2023Q4	us-gaap	Assets Assets	44753000	usd
CY2022Q4	us-gaap	Assets Assets	42040000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1883000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1267000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1015000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1339000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	100000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	168000	usd
CY2023Q4	spcb	Other Long Term Liabilites OtherLongTermLiabilites	583000	usd
CY2022Q4	spcb	Other Long Term Liabilites OtherLongTermLiabilites	1070000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-102926000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3131000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2657000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-6005000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-663000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1751000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4022000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.6
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.6
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.8
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.8
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6762038	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6762038	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2619810	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2619810	shares
CY2022	spcb	Stock Issued During Period Value Conversion Of Loans StockIssuedDuringPeriodValueConversionOfLoans	211000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	usd
CY2022	spcb	Stock Issued During Period Consideration Transferred StockIssuedDuringPeriodConsiderationTransferred	6389000	usd
CY2022	spcb	Share Issuance Expenses ShareIssuanceExpenses	543000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5846000	usd
CY2023	spcb	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	3292000	usd
CY2023	spcb	Stock Issued During Period Consideration Transferred StockIssuedDuringPeriodConsiderationTransferred	1393000	usd
CY2023	spcb	Share Issuance Expenses ShareIssuanceExpenses	113000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1280000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	4816000	usd
CY2023	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-2148000	usd
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-2360000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2980000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2691000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	243000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	138000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-299000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2313000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2023	spcb	Increase Decrease In Allowance For Bad Debts IncreaseDecreaseInAllowanceForBadDebts	1457000	usd
CY2022	spcb	Increase Decrease In Allowance For Bad Debts IncreaseDecreaseInAllowanceForBadDebts	1000000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	180000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	138000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4135000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	791000	usd
CY2023	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1652000	usd
CY2023	spcb	Proceeds From Option And Warrant Exercises ProceedsFromOptionAndWarrantExercises	1819000	usd
CY2022	spcb	Proceeds From Option And Warrant Exercises ProceedsFromOptionAndWarrantExercises	0	usd
CY2023	spcb	Proceeds From Share Issuance Net ProceedsFromShareIssuanceNet	5054000	usd
CY2022	spcb	Proceeds From Share Issuance Net ProceedsFromShareIssuanceNet	5848000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5577000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	spcb	Amount Of Direct Offering Cost AmountOfDirectOfferingCost	2400000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	485000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1032615	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.00001
CY2023Q1	spcb	Concurrent Private Placement Of Class Of Warrants Or Rights Number Of Securities Called By Warrants Or Rights ConcurrentPrivatePlacementOfClassOfWarrantsOrRightsNumberOfSecuritiesCalledByWarrantsOrRights	1517615	shares
CY2023Q1	spcb	Concurrent Private Placement Of Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ConcurrentPrivatePlacementOfClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	1.66
CY2023Q3	spcb	Amount Of Direct Offering Cost AmountOfDirectOfferingCost	2750000	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	661000	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	2574295	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.00001
CY2023Q3	spcb	Concurrent Private Placement Of Class Of Warrants Or Rights Number Of Securities Called By Warrants Or Rights ConcurrentPrivatePlacementOfClassOfWarrantsOrRightsNumberOfSecuritiesCalledByWarrantsOrRights	3235295	shares
CY2023Q3	spcb	Concurrent Private Placement Of Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ConcurrentPrivatePlacementOfClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	0.85
CY2023Q4	spcb	Amount Of Direct Offering Cost AmountOfDirectOfferingCost	2000000	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1081000	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	3671910	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.00001
CY2023Q4	spcb	Concurrent Private Placement Of Class Of Warrants Or Rights Number Of Securities Called By Warrants Or Rights ConcurrentPrivatePlacementOfClassOfWarrantsOrRightsNumberOfSecuritiesCalledByWarrantsOrRights	9505820	shares
CY2023Q4	spcb	Concurrent Private Placement Of Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ConcurrentPrivatePlacementOfClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	0.5
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font-family:'Times New Roman', Times, serif;font-size:10pt;width:100%;text-align:left;color:#000000"> <tr> <td style="width:7%;vertical-align:top"> <div style="line-height:1.25"> </div> </td> <td style="width:3%;vertical-align:top"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">a.</span></span></div> </td> <td style="width:90%;vertical-align:top"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of estimates:</span></span></div> <div style="line-height:1.25"> </div> <div style="line-height:1.25"> <div style="line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of the financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. As applicable to these financial statements, the most significant estimates and assumptions include (i) Revenue Recognition; (ii) Allowance for Doubtful Accounts; (iii) Deferred Income Taxes and (iv) measurement of the fair value of intangible assets and goodwill.</span></span></div> </div> </td> </tr> </table>
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10575000	shares
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	133000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	27019000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	21443000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5576000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	25367000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19750000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5617000	usd
CY2023Q4	spcb	Severance Pay Funds SeverancePayFunds	0	usd
CY2022Q4	spcb	Severance Pay Funds SeverancePayFunds	482000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	501000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	501000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	487000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	484000	usd
CY2023Q4	spcb	Other Long Term Assets OtherLongTermAssets	988000	usd
CY2022Q4	spcb	Other Long Term Assets OtherLongTermAssets	1467000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	701000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	475000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	694000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	502000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	652000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q4	spcb	Operating Lease Right Of Use Asset Other OperatingLeaseRightOfUseAssetOther	1824000	usd
CY2022Q4	spcb	Operating Lease Right Of Use Asset Other OperatingLeaseRightOfUseAssetOther	1200000	usd
CY2023Q4	spcb	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	1337000	usd
CY2022Q4	spcb	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	716000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	487000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	484000	usd
CY2023Q4	spcb	Lease Liabilities Current Accrued Expenses And Other Liabilities LeaseLiabilitiesCurrentAccruedExpensesAndOtherLiabilities	401000	usd
CY2022Q4	spcb	Lease Liabilities Current Accrued Expenses And Other Liabilities LeaseLiabilitiesCurrentAccruedExpensesAndOtherLiabilities	381000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	108000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	108000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	509000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	489000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.09	pure
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	305000	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	269000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	170000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	170000	usd
CY2023Q4	spcb	Accrued Severance Pay AccruedSeverancePay	0	usd
CY2022Q4	spcb	Accrued Severance Pay AccruedSeverancePay	523000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	108000	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	108000	usd
CY2023Q4	spcb	Other Long Term Liabilites OtherLongTermLiabilites	583000	usd
CY2022Q4	spcb	Other Long Term Liabilites OtherLongTermLiabilites	1070000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	24106000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	21362000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	4939000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	4475000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	29045000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-925000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1784000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	943000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1185000	usd
CY2023	spcb	Income Tax Reconciliation Change In Exchange Rate IncomeTaxReconciliationChangeInExchangeRate	576000	usd
CY2022	spcb	Income Tax Reconciliation Change In Exchange Rate IncomeTaxReconciliationChangeInExchangeRate	481000	usd
CY2023Q2	spcb	Number Of Prefunded Warrants NumberOfPrefundedWarrants	440615	shares
CY2023Q2	spcb	Conversion Of Prefunded Warrants Into Ordinary Shares ConversionOfPrefundedWarrantsIntoOrdinaryShares	440615	shares
CY2023Q3	spcb	Number Of Prefunded Warrants NumberOfPrefundedWarrants	435000	shares
CY2023Q3	spcb	Conversion Of Prefunded Warrants Into Ordinary Shares ConversionOfPrefundedWarrantsIntoOrdinaryShares	435000	shares
CY2023Q3	spcb	Concurrent Private Placement Of Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ConcurrentPrivatePlacementOfClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	0.85
CY2023Q3	spcb	Number Of Prefunded Warrants NumberOfPrefundedWarrants	157000	shares
CY2023Q3	spcb	Conversion Of Prefunded Warrants Into Ordinary Shares ConversionOfPrefundedWarrantsIntoOrdinaryShares	157000	shares
CY2023Q1	spcb	Issuance Expenses IssuanceExpenses	188000	usd
CY2023Q1	spcb	Derivative Warrant Liabilities DerivativeWarrantLiabilities	126000	usd
CY2023Q1	spcb	Allocation Of Ordinary Shares To Prefunded Warrants AllocationOfOrdinarySharesToPrefundedWarrants	62000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.036	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0457	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	1	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	1.16	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y4M17D
CY2023Q3	spcb	Number Of Prefunded Warrants NumberOfPrefundedWarrants	765295	shares
CY2023Q3	spcb	Conversion Of Prefunded Warrants Into Ordinary Shares ConversionOfPrefundedWarrantsIntoOrdinaryShares	765295	shares
CY2023Q4	spcb	Number Of Prefunded Warrants NumberOfPrefundedWarrants	1809000	shares
CY2023Q4	spcb	Conversion Of Prefunded Warrants Into Ordinary Shares ConversionOfPrefundedWarrantsIntoOrdinaryShares	1809000	shares
CY2023Q3	spcb	Issuance Expenses IssuanceExpenses	235000	usd
CY2023Q3	spcb	Derivative Warrant Liabilities DerivativeWarrantLiabilities	185000	usd
CY2023Q3	spcb	Allocation Of Ordinary Shares To Prefunded Warrants AllocationOfOrdinarySharesToPrefundedWarrants	50000	usd
CY2023	spcb	Conversion Of Prefunded Warrants Into Ordinary Shares ConversionOfPrefundedWarrantsIntoOrdinaryShares	1081000	shares
CY2023Q4	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	2000000	usd
CY2023Q4	spcb	Issuance Expenses IssuanceExpenses	177000	usd
CY2023Q4	spcb	Number Of Prefunded Warrants NumberOfPrefundedWarrants	2731910	shares
CY2023Q4	spcb	Issuance Of Prefunded Warrants IssuanceOfPrefundedWarrants	3671910	shares
CY2023Q4	spcb	Conversion Of Prefunded Warrants Into Ordinary Shares ConversionOfPrefundedWarrantsIntoOrdinaryShares	2731910	shares
CY2023	spcb	Number Of Prefunded Warrants Remained Outstanding NumberOfPrefundedWarrantsRemainedOutstanding	940000	shares
CY2023Q4	spcb	Accrued Interest Of Short Term Debt AccruedInterestOfShortTermDebt	500000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	22000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.74	pure
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.51
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	811050	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.58
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	416975	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.8
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	213597	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.15
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	597453	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.51
CY2023	spcb	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsGrantsInPeriodGross	22000	shares
CY2023	spcb	Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.23
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	204978	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	3.46
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	9275	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	3.68
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	405200	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.2
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	138000	usd
CY2023Q4	spcb	Accrued Management Services AccruedManagementServices	86000	usd
CY2022Q4	spcb	Accrued Management Services AccruedManagementServices	86000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	26570000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2701000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	17649000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1640000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	26570000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	17649000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1457000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	12667000	usd
CY2023	spcb	Change In Fair Value Of Derivative Warrants Liabilities ChangeInFairValueOfDerivativeWarrantsLiabilities	-2313000	usd
CY2022	spcb	Change In Fair Value Of Derivative Warrants Liabilities ChangeInFairValueOfDerivativeWarrantsLiabilities	0	usd

Files In Submission

Name	View Source	Status
0001178913-24-001418-index-headers.html	Edgar Link	pending
0001178913-24-001418-index.html	Edgar Link	pending
0001178913-24-001418.txt	Edgar Link	pending
0001178913-24-001418-xbrl.zip	Edgar Link	pending
exhibit_12-1.htm	Edgar Link	pending
exhibit_12-2.htm	Edgar Link	pending
exhibit_13-1.htm	Edgar Link	pending
exhibit_13-2.htm	Edgar Link	pending
exhibit_15-1.htm	Edgar Link	pending
exhibit_97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
image1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
spcb-20231231.xsd	Edgar Link	pending
zk2431316.htm	Edgar Link	pending
spcb-20231231_def.xml	Edgar Link	unprocessable
spcb-20231231_lab.xml	Edgar Link	unprocessable
zk2431316_htm.xml	Edgar Link	completed
spcb-20231231_cal.xml	Edgar Link	unprocessable
spcb-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SPCB
SuperCom Ltd Stock $spcb

2023 Q4 Form 20-F Financial Statement

#000117891324001418 Filed on April 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SPCB SuperCom Ltd Stock $spcb

2023 Q4 Form 20-F Financial Statement

#000117891324001418 Filed on April 22, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SPCB
SuperCom Ltd Stock $spcb